semaglutide shaking Side Effects: Common, Severe, Long Term Hypoglycaemia from GLP-1 Injections -

Nervous system Very common (10% or more): Dysesthesia (up to 22%), headache (up to 17%) Common (1% to 10%): Dizziness, dysgeusia Uncommon (0.1% to 1%): Syncope Postmarketing reports : Headache, dizziness, dysgeusia, dysesthesia Dysesthesia included allodynia, burning sensation, hyperesthesia, hyperpathia, pain of skin, paresthesia, sensitive skin, skin burning sensation, skin discomfort, and skin sensitization

It might balance neurotransmitters like dopamine and serotonin, showing promise in neurological conditions such as schizophrenia and encephalopathies

The relationship between semaglutide and muscle wasting Sold under the name Ozempic, semaglutide is a peptide that acts like GLP-1

Moreover, persistent hyperglycaemia triggers activation of the (NF-B) pathway and release of pro-inflammatory factors, leading to an imbalance between the pro- and anti-inflammatory networks, resulting in an increase in reactive oxygen species and the production of a large number of inflammatory mediators, which affects the functioning of the mitochondria and leads to neuronal damage and degeneration (29)

They first analyzed data from an earlier long COVID study involving 90 people hospitalized with COVID-19, including 11 with type 2 diabetes and 79 without